Abstract |
Patients with primary central nervous system lymphoma (PCNSL) after treatment with natalizumab have been considered co-incidental. We report another case of PCNSL in a patient where the explosive onset suggests a causal link.
|
Authors | Angelika Na, Nick Hall, Bhadrakant Kavar, John King |
Journal | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
(J Clin Neurosci)
Vol. 21
Issue 6
Pg. 1068-70
(Jun 2014)
ISSN: 1532-2653 [Electronic] Scotland |
PMID | 24373819
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antibodies, Monoclonal, Humanized
- Natalizumab
|
Topics |
- Adult
- Antibodies, Monoclonal, Humanized
(adverse effects)
- Central Nervous System Neoplasms
(chemically induced, diagnosis)
- Fatal Outcome
- Humans
- Lymphoma
(chemically induced, diagnosis)
- Male
- Natalizumab
|